Keck School Faculty

Juliet Ann Emamaullee
Juliet Ann Emamaullee
Assistant Professor Of Clinical Surgery
Surgery
1520 San Pablo Street Health Sciences Campus Los Angeles
Dr. Emamaullee is an Assistant Professor of Clinical Surgery at the USC Keck School of Medicine and an attending transplant surgeon at Keck Hospital of USC and Children's Hospital-Los Angeles. She is a surgeon-scientist with a translational immunology lab, with a research focus on immunological phenotypes associated with liver transplant recipients. Dr. Emamaullee’s other research interests include living donor liver transplantation, Hepatitis C and its impact on hepatocellular carcinoma, and tolerance strategies to improve allograft survival.

Dr. Emamaullee received her B.Sc. in Chemistry (Honors) in 2000 from the University of Alabama, where she also competed on the varsity volleyball team. She completed her Ph.D. in Immunology at the University of Alberta, in Edmonton, Alberta, Canada in 2005, and her involvement in the clinical transplant program inspired her to pursue a career in medicine. She graduated from medical school at the University of Alberta in 2010. During her time in medical school, Dr. Emamaullee was involved in research as JDRF/ASTS funded postdoctoral fellow in the lab of Dr. James Shapiro, director of the Clinical Islet Transplant Program at the University of Alberta. Dr. Emamaullee completed her residency in General Surgery at Emory University in Atlanta, GA in 2015. She returned to the University of Alberta for fellowship training in transplant and hepatobiliary surgery and joined the faculty of USC upon completion, in the Fall of 2017.

Dr. Emamaullee has been involved at the committee level in the Association of Women Surgeons and the American College of Surgeons since 2005. She has been the recipient of numerous awards including the AWS Patricia Numann Medical Student Award and the Canadian Medical Association Award for Young Leaders in Medicine.

Outcomes of Liver Transplantation in Patients on Renal Replacement Therapy: Considerations for Simultaneous Liver Kidney Transplantation Versus Safety Net Transplant Direct. 2019 Oct; 5(10):e490. . View in PubMed

Use of Donation after Cardiac Death Donors at the University of Southern California J Am Coll Surg. 2019 Oct; 229(4):437-438. . View in PubMed

Immunologic benefit of maternal donors in pediatric living donor liver transplantation Pediatr Transplant. 2019 Aug 11; e13560. . View in PubMed

Chronically Retained Central Venous Catheter in Deceased Donor Liver Allograft Case Rep Transplant. 2019; 2019:4359197. . View in PubMed

HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation Can J Gastroenterol Hepatol. 2019; 2019:2509059. . View in PubMed

Case series and systematic review of acquired diaphragmatic hernia after liver transplantation Pediatr Transplant. 2018 12; 22(8):e13296. . View in PubMed

Hepatic Epithelioid Hemangioendothelioma Presenting as an Enlarging Vascular Lesion within the Spleen Case Rep Transplant. 2018; 2018:3948784. . View in PubMed

Profiles in Surgical Research: John Alverdy, MD FACS Bull Am Coll Surg. 2018; 10(103):21-28. . View in PubMed

Preliminary Single-Center Canadian Experience of Human Normothermic Ex Vivo Liver Perfusion: Results of a Clinical Trial Am J Transplant. 2017 04; 17(4):1071-1080. . View in PubMed

Profiles in surgical research: Mary THawn, MD, MPH, FACS. Bull Am Coll Surg. 2017 01; 102(1):26-32. . View in PubMed

Profiles in surgical research: Anthony Atala, MD, FAC5 Bull Am Coll Surg. 2016 May; 101(5):30-5. . View in PubMed

Profiles in surgical research: Dorry LSegev, MD, PhD, FACS. Bull Am Coll Surg. 2015 Jul; 100(7):27-33. . View in PubMed

Profiles in surgical research: Michael RHarrison, MD, FACS. Bull Am Coll Surg. 2015 Jan; 100(1):35-40. . View in PubMed

Improved communication techniques enable residents to provide better care now and in the future Bull Am Coll Surg. 2013 Aug; 98(8):26-32. . View in PubMed

Women leaders in surgery: past, present, and future Bull Am Coll Surg. 2012 Aug; 97(8):24-9. . View in PubMed

Caspase inhibitor IDN6556 facilitates marginal mass islet engraftment in a porcine islet autotransplant model Transplantation. 2012 Jul 15; 94(1):30-5. . View in PubMed

AEB071 (sotrastaurin) does not exhibit toxic effects on human islets in vitro, nor after transplantation into immunodeficient mice Islets. 2011 Nov-Dec; 3(6):338-43. . View in PubMed

The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in mice Surgery. 2011 Jul; 150(1):48-55. . View in PubMed

Education and imagingHepatobiliary and pancreatic: Multinodular fatty liver associated with porphyria cutanea tarda. J Gastroenterol Hepatol. 2011 Jan; 26(1):211. . View in PubMed

Caspase inhibitor therapy synergizes with costimulation blockade to promote indefinite islet allograft survival Diabetes. 2010 Jun; 59(6):1469-77. . View in PubMed

Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture Transpl Int. 2010 Mar 01; 23(3):259-65. . View in PubMed

Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: Implications for treatment and surgical management Liver Transpl. 2010 Feb; 16(2):191-7. . View in PubMed

Histologic graft assessment after clinical islet transplantation Transplantation. 2009 Dec 15; 88(11):1286-93. . View in PubMed

Costimulatory blockade with belatacept in clinical and experimental transplantation - a review Expert Opin Biol Ther. 2009 Jun; 9(6):789-96. . View in PubMed

Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice Diabetes. 2009 Jun; 58(6):1302-11. . View in PubMed

Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide Endocrinology. 2009 May; 150(5):2145-52. . View in PubMed

AEB-071 has minimal impact on onset of autoimmune diabetes in NOD mice Autoimmunity. 2009 Mar; 42(3):242-8. . View in PubMed

Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation Transpl Int. 2009 Feb; 22(2):182-91. . View in PubMed

Protein kinase C inhibitor, AEB-071, acts complementarily with cyclosporine to prevent islet rejection in rats Transplantation. 2009 Jan 15; 87(1):59-65. . View in PubMed

Optimal implantation site for pancreatic islet transplantation Br J Surg. 2008 Dec; 95(12):1449-61. . View in PubMed

The role of macrophage migration inhibitory factor in mouse islet transplantation Transplantation. 2008 Nov 27; 86(10):1361-9. . View in PubMed

The role of macrophage migration inhibitory factor on glucose metabolism and diabetes Diabetologia. 2008 Nov; 51(11):1937-46. . View in PubMed

Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice Endocrinology. 2008 Sep; 149(9):4322-8. . View in PubMed

The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice Diabetes. 2008 Jun; 57(6):1556-66. . View in PubMed

Belatacept and basiliximab diminish human antiporcine xenoreactivity and synergize to inhibit alloimmunity Transplantation. 2008 Jan 15; 85(1):118-24. . View in PubMed

Human islet function is not impaired by the sphingosine-1-phosphate receptor modulator FTY720 Am J Transplant. 2007 Aug; 7(8):2031-8. . View in PubMed

Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation Diabetes. 2007 May; 56(5):1289-98. . View in PubMed

Factors Influencing the Loss of ß-Cell Mass in Islet Transplantation Cell Transplant. 2007 Jan; 16(1):1-8. . View in PubMed

Factors influencing the loss of beta-cell mass in islet transplantation Cell Transplant. 2007; 16(1):1-8. . View in PubMed

Neonatal porcine islets exhibit natural resistance to hypoxia-induced apoptosis Transplantation. 2006 Oct 15; 82(7):945-52. . View in PubMed

Interventional strategies to prevent beta-cell apoptosis in islet transplantation Diabetes. 2006 Jul; 55(7):1907-14. . View in PubMed

XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes Diabetes. 2005 Sep; 54(9):2541-8. . View in PubMed

XIAP overexpression in islet beta-cells enhances engraftment and minimizes hypoxia-reperfusion injury Am J Transplant. 2005 Jun; 5(6):1297-305. . View in PubMed

The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin J Biol Inorg Chem. 2001 Jun; 6(5-6):608-17. . View in PubMed

The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferrin and chromium picolinate to LMWCr J Biol Inorg Chem. 2000 Feb; 5(1):129-36. . View in PubMed

The biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ decreases plasma cholesterol and triglycerides in rats: towards chromium-containing therapeutics J Biol Inorg Chem. 1999 Dec; 4(6):838-45. . View in PubMed

Powered by SC CTSI
Go to Top